Follow this preprint
Efficacy and safety of novel probiotic formulation in adult Covid19 outpatients: a randomized, placebo-controlled clinical trial
View ORCID ProfilePedro Gutiérrez-Castrellón, Tania Gandara-Martí, Ana Teresa Abreu, Cesar D. Nieto-Rufino, Eduardo López-Orduña, Irma Jiménez-Escobar, Carlos Jiménez-Gutiérrez, Gabriel López-Velazquez, View ORCID ProfileJordi Espadaler-Mazo
doi: https://doi.org/10.1101/2021.05.20.21256954
Now published in Gut Microbes doi: 10.1080/19490976.2021.2018899
Pedro Gutiérrez-Castrellón
1Centro de Investigación Translacional en Ciencias de la Salud, Hospital General Dr. Manuel Gea Gonzalez. Calz. De Tlalpan 4800, 14080 Ciudad de México, (CDMX), México
2International Scientific Council for Probiotics, Tenango 22, 14340, Ciudad de México, (CDMX), México
PhDTania Gandara-Martí
1Centro de Investigación Translacional en Ciencias de la Salud, Hospital General Dr. Manuel Gea Gonzalez. Calz. De Tlalpan 4800, 14080 Ciudad de México, (CDMX), México
MDAna Teresa Abreu
3Hospital Angeles Pedregal, Camino de Sta. Teresa 1055-S, 10700, Ciudad de México, (CDMX), México
MDCesar D. Nieto-Rufino
1Centro de Investigación Translacional en Ciencias de la Salud, Hospital General Dr. Manuel Gea Gonzalez. Calz. De Tlalpan 4800, 14080 Ciudad de México, (CDMX), México
MDEduardo López-Orduña
4DiagnoMol SA de CV. Camino Sta. Teresa No 13, 14110 Ciudad de México (CDMX), México
PhDIrma Jiménez-Escobar
1Centro de Investigación Translacional en Ciencias de la Salud, Hospital General Dr. Manuel Gea Gonzalez. Calz. De Tlalpan 4800, 14080 Ciudad de México, (CDMX), México
MHMCarlos Jiménez-Gutiérrez
1Centro de Investigación Translacional en Ciencias de la Salud, Hospital General Dr. Manuel Gea Gonzalez. Calz. De Tlalpan 4800, 14080 Ciudad de México, (CDMX), México
DPHGabriel López-Velazquez
2International Scientific Council for Probiotics, Tenango 22, 14340, Ciudad de México, (CDMX), México
PhDJordi Espadaler-Mazo
5AB-Biotics SA (KANEKA Group), R&D Department, Av. De Torre Blanca 57, 08172 Sant Cugat, (Barcelona), Spain
PhD
Data Availability
Deidentified individual patient data (IPD), together with data dictionary defining each field in the set, will be made public upon any formal requests with a defined analysis plan. To make a request, please contact the corresponding author (espadaler{at}ab-biotics.com). Decision to make IPD publicly available was taken after initial trial registration.
Posted May 24, 2021.
Efficacy and safety of novel probiotic formulation in adult Covid19 outpatients: a randomized, placebo-controlled clinical trial
Pedro Gutiérrez-Castrellón, Tania Gandara-Martí, Ana Teresa Abreu, Cesar D. Nieto-Rufino, Eduardo López-Orduña, Irma Jiménez-Escobar, Carlos Jiménez-Gutiérrez, Gabriel López-Velazquez, Jordi Espadaler-Mazo
medRxiv 2021.05.20.21256954; doi: https://doi.org/10.1101/2021.05.20.21256954
Now published in Gut Microbes doi: 10.1080/19490976.2021.2018899
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
2
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (420)
- Allergy and Immunology (744)
- Anesthesia (217)
- Cardiovascular Medicine (3204)
- Dermatology (270)
- Emergency Medicine (475)
- Epidemiology (13203)
- Forensic Medicine (19)
- Gastroenterology (884)
- Genetic and Genomic Medicine (5031)
- Geriatric Medicine (469)
- Health Economics (770)
- Health Informatics (3166)
- Health Policy (1121)
- Hematology (419)
- HIV/AIDS (997)
- Medical Education (467)
- Medical Ethics (124)
- Nephrology (512)
- Neurology (4777)
- Nursing (253)
- Nutrition (707)
- Oncology (2460)
- Ophthalmology (698)
- Orthopedics (275)
- Otolaryngology (335)
- Pain Medicine (318)
- Palliative Medicine (89)
- Pathology (527)
- Pediatrics (1272)
- Primary Care Research (545)
- Public and Global Health (7338)
- Radiology and Imaging (1659)
- Respiratory Medicine (961)
- Rheumatology (470)
- Sports Medicine (413)
- Surgery (532)
- Toxicology (68)
- Transplantation (227)
- Urology (197)